Status:
TERMINATED
Weight Management for the Remission of Type 2 Diabetes Using a Proprietary Meal Replacement System- Diabetes Remission Study (DRS)
Lead Sponsor:
Loma Linda University
Conditions:
Obesity
Diabetes Mellitus, Type 2
Eligibility:
All Genders
25-65 years
Phase:
NA
Brief Summary
A three month meal replacement dietary system which combines meal replacements and self-prepared meals which hypothetically will result in Diabetes remission in \>30% of intervention subjects To asse...
Eligibility Criteria
Inclusion
- Men and Women
- Ages 25-65
- Have been diagnosed with non-insulin dependent diabetes for less than five years
- Are taking at least one oral agents for diabetes
- English speaking
Exclusion
- Individuals currently being treated for cancer
- Had a myocardial infarction in the previous 3 months
- Have uncontrolled persistent hypertension - diastolic \>90 systolic \>160
- Individuals with established eating disorder diagnoses
- Individuals who have recent weight loss attempt in the last 3 months with \> 5-pound loss
- Use of anti-obesity medications in the last three months
- Individuals who have had bariatric surgery
- Individuals taking medications that are known to cause weight gain including but not limited to insulin, steroids, haloperidol clozapine, risperidone, olanzapine, amitriptyline imipramine, paroxetine, and lithium
- Individuals who are pregnant or planning to become pregnant in the next 6 months
Key Trial Info
Start Date :
December 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 14 2023
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT05397028
Start Date
December 8 2022
End Date
March 14 2023
Last Update
January 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University Health
Loma Linda, California, United States, 92350